mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open

Nephrol Dial Transplant. 2013 Feb;28(2):242-4. doi: 10.1093/ndt/gfs519. Epub 2012 Dec 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases, Cystic / drug therapy*
  • Male
  • Polycystic Kidney, Autosomal Dominant / drug therapy*
  • Sirolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Sirolimus